Cantor Fitzgerald Reiterates Overweight Rating on aTyr Pharma (ATYR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: ATYR) | Delayed: 5.37 +5.24 (4,030.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.13 | 52 Week High | $ | |||
| Open | $4.83 | 52 Week Low | $ | |||
| Day High | $5.60 | P/E | N/A | |||
| Day Low | $4.81 | EPS | $ | |||
| Volume | 227,418 | |||||
